V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10394095 | 10069072 | 1.66 | 61.1 | Palliative (P) | 2019-12-17 | 2020-01-20 | Capecitabine (21 day) + Irinotecan | 02 | null | CETUXIMAB | 101313413 |
| 10394438 | 10069074 | 0 | 46 | 03 | 2018-01-30 | 2018-02-08 | BUSULFAN | 02 | N | BUSULFAN | 101616712 |
| 10394516 | 10069075 | 1.8 | 67 | Palliative (P) | 2020-02-04 | 2020-02-04 | Chlorambucil | 02 | N | CHLORAMBUCIL | 101465613 |
| 10394555 | 10069076 | 1.87 | 57.5 | Palliative (P) | 2018-10-11 | 2019-02-16 | Palbociclib | 02 | N | PALBOCICLIB | 101766674 |
| 10394802 | 10069077 | 1.68 | 68.1 | null | 2020-02-25 | 2020-02-25 | CISPLATIN + RT | 02 | null | ACALABRUTINIB | 100768299 |
| 10395391 | 10069078 | 1.81 | 71.6 | 03 | 2020-09-12 | 2020-09-12 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 100933024 |
| 10395783 | 10069079 | 1.75 | 66 | Palliative (P) | 2019-05-09 | 2019-05-09 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | CHLORAMBUCIL + OBINUTUZUMAB | 100563493 |
| 10396943 | 10069081 | 1.72 | 71 | Neo-adjuvant (N) | 2018-06-28 | 2018-07-13 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | Y | CHLORAMBUCIL + OBINUTUZUMAB | 101240498 |
| 10397323 | 10069082 | 1.77 | 78.6 | Palliative (P) | 2017-09-17 | 2017-09-23 | CVP R | 02 | N | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 101420043 |
| 10397511 | 10069083 | 1.74 | 97 | Palliative (P) | 2017-10-18 | 2018-04-16 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 100559080 |
| 10397618 | 10069084 | 1.68 | 87.2 | null | 2019-08-22 | 2019-08-26 | Melphalan IV High dose | 02 | null | MELPHALAN | 101547259 |
| 10398606 | 10069085 | 1.67 | 91.75 | Palliative (P) | 2018-02-09 | 2018-02-24 | Fluorouricil + Folonic Acid (MdG) | 02 | Y | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101834453 |
| 10398750 | 10069086 | 1.68 | 64.5 | null | 2017-12-26 | 2018-11-08 | Trifluridine + Tipiracil | 02 | null | TIPIRACIL + TRIFLURIDINE | 100784661 |
| 10399803 | 10069088 | 1.7 | 64 | 03 | 2019-12-28 | 2019-12-29 | Chlorambucil | 02 | N | CHLORAMBUCIL | 100479259 |
| 10402271 | 10069092 | 1.62 | 63.4 | null | 2020-09-19 | 2020-09-26 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100145504 |
| 10402433 | 10069094 | 1.63 | 60.4 | null | 2018-07-16 | 2018-07-16 | CISPLATIN + VINORELBINE + RT | 02 | null | BUSULFAN | 101657710 |
| 10403107 | 10069097 | 1.69 | 70 | null | null | 2018-03-01 | IPILIMUMAB + NIVOLUMAB | 02 | N | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 101573942 |
| 10404444 | 10069100 | 1.65 | 101.6 | Disease modification (D) | 2020-12-01 | 2020-12-16 | null | 02 | N | CAPECITABINE + CISPLATIN | 101732737 |
| 10404614 | 10069101 | null | null | null | 2019-06-24 | 2019-06-24 | Obinutuzumab +CVP | 2 | N | EPIRUBICIN + VINCRISTINE | 101714696 |
| 10405042 | 10069102 | 1.71 | 66.6 | null | 2017-11-26 | 2017-12-23 | GEFITINIB | 02 | null | OBINUTUZUMAB + VENETOCLAX | 101692462 |
| 10405190 | 10069103 | 1.66 | 81.6 | null | 2018-01-14 | 2018-04-08 | ANAGRELIDE | null | null | NINTEDANIB | 100121130 |
| 10405823 | 10069104 | 1.72 | 70.7 | null | 2020-11-03 | 2020-11-03 | Abemaciclib | null | null | R-EPOCH | 101016992 |
| 10405992 | 10069105 | 1.74 | 0 | null | 2018-10-11 | 2018-10-11 | BCG Intravesical | 02 | null | TOPOTECAN | 101791626 |
| 10406306 | 10069106 | 1.61 | 82.9 | Not known (9) | 2019-09-21 | 2019-11-22 | Liposomal Doxorubicin 40mg/m2 | 02 | null | CARBOPLATIN + FLUOROURACIL | 101444411 |
| 10407673 | 10069108 | 1.71 | 60 | null | 2017-08-24 | 2017-08-24 | Cisplatin + Fluorouracil + RT 5day | null | null | IDELALISIB + RITUXIMAB | 101636867 |
| 10408909 | 10069109 | null | null | Palliative (P) | 2018-07-05 | 2018-07-05 | Brentuximab Vedotin | 02 | N | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 101262958 |
| 10409363 | 10069110 | null | null | Palliative (P) | 2018-10-22 | 2019-08-19 | ISATUXIMAB + POMALIDOMIDE | 02 | N | LOMUSTINE + PROCARBAZINE + VINCRISTINE | 101422272 |
| 10409542 | 10069111 | 1.6 | 117 | Palliative (P) | 2020-08-05 | 2020-08-26 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 02 | N | GILTERITINIB | 100586671 |
| 10410684 | 10069113 | null | null | 03 | 2013-05-09 | 2018-04-12 | Tivozanib | 02 | N | CAPECITABINE + CARBOPLATIN | 100401278 |
| 10410827 | 10069114 | null | null | Palliative (P) | 2020-09-05 | 2020-09-05 | Trastuzumab(Kadcyla®) (Maintenance) | 02 | N | ANAGRELIDE | 101432799 |
| 10411344 | 10069115 | 1.69 | 61 | Palliative (P) | 2020-11-26 | 2020-11-26 | BLEOMYCIN | 02 | N | CHOP R | 101332368 |
| 10412204 | 10069116 | null | null | null | 2019-12-24 | 2020-08-02 | Nintedanib | 02 | null | CAPECITABINE + MITOMYCIN | 100986138 |
| 10412394 | 10069118 | null | null | null | 2017-12-28 | 2018-01-14 | CAV | 02 | null | DOCETAXEL + NINTEDANIB | 100190269 |
| 10412690 | 10069119 | null | null | 03 | null | 2022-01-01 | PMitCEBO-R | null | N | CAPECITABINE + CARBOPLATIN | 100651306 |
| 10413115 | 10069121 | 1.86 | 98.4 | null | 2018-06-09 | 2019-09-02 | EC | 02 | null | ISATUXIMAB + POMALIDOMIDE | 100287870 |
| 10413781 | 10069123 | 0 | 78.2 | Adjuvant (A) | 2020-01-19 | 2020-01-19 | VISMODEGIB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100236851 |
| 10414088 | 10069124 | null | null | null | 2019-08-29 | 2019-08-30 | Bexarotene | Y | null | AZACITIDINE + VENETOCLAX | 101747330 |
| 10414161 | 10069125 | 1.8 | 80 | null | 2020-08-26 | 2020-09-30 | null | 02 | null | CAPECITABINE + MITOMYCIN | 100123637 |
| 10414433 | 10069126 | 1.73 | 56.7 | null | null | 2018-05-11 | Obinutuzumab | null | null | CAPECITABINE + CARBOPLATIN | 100008163 |
| 10414738 | 10069128 | 1.72 | 68 | 03 | null | 2019-03-19 | Doxorubicin + Olaratumab | 02 | N | FOCUS4 TRIAL | 100011192 |
| 10415125 | 10069130 | 1.86 | 79 | null | 2021-02-25 | 2022-05-09 | Trial Unspecified | 02 | null | MIDOSTAURIN | 101037935 |
| 10415757 | 10069131 | 1.78 | 87.4 | null | 2016-12-22 | 2017-03-06 | NEPTUNE TRIAL | 02 | null | PERTUZUMAB | 100657848 |
| 10415900 | 10069132 | 1.6 | 70.3 | null | 2020-04-25 | 2020-04-25 | ICON8B TRIAL | 02 | null | BENDAMUSTINE + OBINUTUZUMAB | 101412971 |
| 10416063 | 10069134 | 1.65 | 77.2 | 03 | 2019-09-09 | 2020-11-17 | PEMBROLIZUMAB + PEMETREXED | N | N | ISATUXIMAB + POMALIDOMIDE | 101234752 |
| 10416573 | 10069136 | 1.66 | 116 | Palliative (P) | null | 2018-05-15 | Durvalumab | null | N | OLAPARIB | 101836152 |
| 10416647 | 10069137 | null | null | null | 2017-11-26 | 2018-02-16 | VISMODEGIB | 02 | null | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 100367459 |
| 10417251 | 10069139 | 1.67 | 80.6 | Palliative (P) | 2019-03-03 | 2019-03-05 | MPV (cycle 5-9) - maintenance | 02 | N | TRANSPLANT CARMUSTINE + THIOTEPA | 101112452 |
| 10417622 | 10069140 | 1.73 | 90 | null | 2020-10-20 | 2020-10-20 | null | 02 | null | MYELOMA XI TRIAL | 101605680 |
| 10418509 | 10069142 | 1.89 | 76 | null | 2018-06-14 | 2018-06-14 | FCarboSt | 2 | N | DICE TRIAL | 101204312 |
| 10418578 | 10069143 | 1.8 | 73.1 | null | 2019-12-12 | 2019-12-20 | Trial Unspecified | 02 | null | AZACITIDINE + VENETOCLAX | 100713107 |